Community-Acquired Pneumonia in Children.
CONCLUSION: In previously healthy children under the age of 5 years, high dose amoxicillin is the treatment of choice. For those with type 1 hypersensitivity to penicillin, clindamycin, azithromycin, clarithromycin, and levofloxacin are reasonable alternatives. For children with a non-type 1 hypersensitivity to penicillin, cephalosporins such as cefixime, cefprozil, cefdinir, cefpodoxime, and cefuroxime should be considered. In previously healthy children over the age of 5 years, macrolides such as azithromycin and clarithromycin are the drugs of choice.
PMID: 29932038 [PubMed - as supplied by publisher]
Source: Recent Patents on Inflammation and Allergy Drug Discovery - Category: Allergy & Immunology Tags: Recent Pat Inflamm Allergy Drug Discov Source Type: research
More News: Allergy | Allergy & Immunology | Amoxicillin | Azithromycin | Biaxin | Cefprozil | Cefuroxime | Cefzil | Children | Chlamydophila | Chlamydophila pneumoniae | Clarithromycin | Clindamycin | Clinical Trials | Haemophilus Influenzae (Hib) | Levaquin | Penicillin | Pneumonia | Respiratory Medicine | Staphylococcus Aureus | Study | Zithromax